DENVER, CO--(NewMediaWire - May 25, 2017) - Ubiquitech Software
Corp. (OTC PINK: UBQU), through its subsidiary HempLife Today™
an innovative and growing Company offering the finest CBD
(Cannabidiol), products derived from Hemp, is announcing its three
to five-year plan to reach $50,000,000 in annual sales revenue.
Company gives overview on how it can achieve this goal and the
progress it is making toward this stated goal.
CEO James Ballas said, "We do our best to keep our shareholders
informed on company progress on a regular basis. But, we also think
it's important for shareholders to know what our goals for the
company are, and how we plan to get there, and showing shareholders
how we plan to get this company to fifty million per year in
revenues, or more, is important to us."
The Company has plans to expand on all areas of the current
business model and many of the sales and marketing platforms
utilized have been explained to shareholders in previous press.
Company growth can also be tied to the gaining popularity of CBD
products by the general public and the Company realizes incremental
quarterly growth based on this public awareness as well. With the
footprint that HempLife Today™ has in the burgeoning CBD market,
and the growing popularity and awareness of its CannazALL™ CBD
brand, the Company plans to make CannazALL™ "the brand" people
think of when they think CBD.
In addition, the Company understands a name and symbol change to
better reflect the sector that the Company is in is of vital
importance to the continued growth and success of the Company, and
its shareholders. The Company wants all shareholders to note that
the name and symbol change is of primary importance and that an
announcement on this subject will be made at the appropriate
time.
The Company currently shows that growth has nearly doubled each
year since 2014 and that the Company also nearly doubled its
database of customers in those same time periods. With the current
five year plan the Company is set to continue this trend and reach
$50,000,000 in annual revenues within the 2020 to 2022
forecast.
The Company wants shareholders to note that it will only take
approximately 1,000 orders per day of its popular CannazALL™ Hemp
derived CBD products, at an average sale price of just $145 per
order, to reach this goal, and that the Company is on track to
achieve this. The Company's current daily, monthly, and yearly
product "orders" is commensurate with this stated goal, and can
continue at the current profit rates as well.
The Company has plans to add more shipping space, programming,
employees, and additional labor in order to keep up with growth.
Processing of Hemp derived CBD Oil to fill 1,000+ orders per day
has already been established and the Company is fully capable of
keeping up with product demand over the next five years and
beyond.
COO, Luke Dreyer adds, "With our grow capabilities, our Rapid
Ship processing, and the streamlined system we've developed to get
product into the hands of our customers, meeting demand as we grow
will not be a problem. In fact we planned it this way, and
everything is in place on the production, distribution, and
shipping side to propel us forward in meeting our five year annual
sales goal. So, we urge our shareholders to stay with us and enjoy
our growth!"
The Company plans to continue using all of its successful
marketing platforms in order to grow to 1,000+ orders per day over
the next 3 - 5 years. These platforms include; targeted content
marketing, extensive Social Media marketing, traditional online
advertising, referral advertising, viral giveaway campaigns, Direct
Mail and email campaigns. Additional details cannot be given due to
the competitive nature of the business and the proprietary nature
of the Company's marketing platforms.
CEO James Ballas added, "We are doing it all, from expanding our
successful marketing platforms, our shipping, packaging, and
customer support, to name and symbol change, all of it. We are
growing, and we are in one of the most exciting new industries
worldwide with more opportunities emerging at an accelerated pace.
What our team has achieved in the last three years is simply
amazing and we know we can reach our goals over the next 3-5 years
as well. We have top products, we take care of our customers, and
we are motivated to be the best in the industry. We will do
everything we can to continue our growth."
The Company looks forward to keeping shareholders informed on a
regular basis to show the progress the Company is making.
About HempLife Today™
Hemp Life Today™ was created by a group of highly motivated,
skilled and health minded people. Who have learned that Hemp, and
Hemp related products, can be a great source of increased health,
vitality, and overall well being in our lives. We also believe that
high grade CBD (Canabidiol), could very well be the miracle
supplement the world has been waiting for as more and more people
discover the health benefits of this remarkable extract. hempLife
Today™ offers its quality CBD products @ www.HempLifeToday.com
About Ubiquitech
Ubiquitech Software Corp, through its subsidiaries is a dynamic
multi-media, multi-faceted corporation utilizing state-of-the-art
global internet marketing, Direct Response (DRTV) Television,
Radio, and traditional marketing, to drive traffic to the new and
emerging multi-billion dollar industries like its subsidiary
HempLifeToday™
HempLifeToday™ focuses on the exciting and dynamic new thinking
in the world today that recognizes the important health and life
enriching enhancement that CBD Oil from the Hemp plant can bring.
Through its network of quality USA growers HempLifeToday.com™ has
developed multiple and proprietary CannazALL™ CBD oil products that
include; It's popular CBD Tinctures, Oils, GelCaps, CBD Powder,
Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com
This press release contains forward-looking statements. Words
such as "expects", "intends'', "believes'', and similar expressions
reflecting something other than historical fact are intended to
identify forward-looking statements, but are not the exclusive
means of identifying such statements. These forward-looking
statements involve a number of risks and uncertainties, including
the timely development and market acceptance of products and
technologies, the ability to secure additional sources of finance,
the ability to reduce operating expenses, and other factors
described in the Company's filings with the OTC Markets Group. The
actual results that the Company achieves may differ materially from
any forward-looking statement due to such risks and uncertainties.
The Company undertakes no obligation to revise or update any
forward- looking statements in order to reflect events or
circumstances that may arise after the date of this release.